2-73448592-A-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1

The NM_001378454.1(ALMS1):​c.2065A>G​(p.Thr689Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000455 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T689P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00046 ( 0 hom. )

Consequence

ALMS1
NM_001378454.1 missense

Scores

1
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: -0.492

Publications

3 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05889699).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000369 (56/151914) while in subpopulation NFE AF = 0.000662 (45/67982). AF 95% confidence interval is 0.000508. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378454.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALMS1
NM_001378454.1
MANE Select
c.2065A>Gp.Thr689Ala
missense
Exon 8 of 23NP_001365383.1Q8TCU4-1
ALMS1
NM_015120.4
c.2065A>Gp.Thr689Ala
missense
Exon 8 of 23NP_055935.4Q8TCU4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALMS1
ENST00000613296.6
TSL:1 MANE Select
c.2065A>Gp.Thr689Ala
missense
Exon 8 of 23ENSP00000482968.1Q8TCU4-1
ALMS1
ENST00000484298.5
TSL:1
c.1939A>Gp.Thr647Ala
missense
Exon 7 of 22ENSP00000478155.1A0A087WTU9
ALMS1
ENST00000684548.1
c.1684A>Gp.Thr562Ala
missense
Exon 6 of 21ENSP00000507421.1A0A804HJA5

Frequencies

GnomAD3 genomes
AF:
0.000369
AC:
56
AN:
151914
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000261
AC:
65
AN:
248908
AF XY:
0.000281
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000928
Gnomad NFE exome
AF:
0.000497
Gnomad OTH exome
AF:
0.000496
GnomAD4 exome
AF:
0.000464
AC:
679
AN:
1461812
Hom.:
0
Cov.:
82
AF XY:
0.000448
AC XY:
326
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33472
American (AMR)
AF:
0.0000447
AC:
2
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000582
AC:
647
AN:
1111962
Other (OTH)
AF:
0.000397
AC:
24
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000369
AC:
56
AN:
151914
Hom.:
0
Cov.:
32
AF XY:
0.000337
AC XY:
25
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41310
American (AMR)
AF:
0.000328
AC:
5
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
67982
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000444
Hom.:
1
Bravo
AF:
0.000348
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000606
AC:
5
ExAC
AF:
0.000215
AC:
26
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Alstrom syndrome (3)
-
3
-
not provided (3)
-
-
1
Cardiovascular phenotype (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.038
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.0048
T
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.49
PrimateAI
Benign
0.30
T
Sift4G
Uncertain
0.043
D
Vest4
0.20
MVP
0.055
ClinPred
0.046
T
GERP RS
-8.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.043
gMVP
0.082
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201804994; hg19: chr2-73675719; COSMIC: COSV52518794; COSMIC: COSV52518794; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.